Novartis Foundation and Partners Launch Initiative to Tackle Hypertension and Its Root Causes in Low-Income Urban Communities

Wed, 05/17/2017 - 02:15

On World Hypertension Day 2017, the Novartis Foundation and its partners, including Intel Corporation, the NCD Alliance, city governments and local partners, announce the launch of Better Hearts Better Cities, an innovative initiative to address the high rates of high blood pressure (hypertension) in low-income urban communities.

World Malaria Day

Tue, 05/16/2017 - 11:25

Malaria is a major public health problem, particularly in sub-Saharan Africa. Transmitted to humans by mosquito bites, this disease kills a child every two minutes in this part of the world.

Novartis Access and Government of Pakistan Sign Memorandum of Understanding

Fri, 05/12/2017 - 11:10

Novartis reaches agreement with Pakistan to supply medicines that address the rapid rise of chronic illness among poor people in the world's sixth most populous nation. Novartis Access medicines will be made available to the poorest population in Pakistan through hospitals under the Prime Minister’s National Health Insurance Program.

De Beers Group Employees Have a Good Hair Day

Mon, 05/15/2017 - 10:00

Employee volunteers at De Beers’ Venetia mine in South Africa have raised cash for the fight against cancer by having their hair sprayed or shaved.

LIVESTRONG Celebrates 20th Anniversary with Launch of Honor 5K/10K

Thu, 04/27/2017 - 17:05

In celebration of its 20th Anniversary, the LIVESTRONG Foundation – a global leader and pioneer in cancer patient survivorship – announced today the launch of The LIVESTRONG Honor 5k/10k, which will take place on September 17 in downtown Austin.

Gilead Publishes Year in Review 2016

Mon, 05/01/2017 - 17:15

Gilead Sciences, Inc. today announced that it issued its Year in Review 2016, a combination of the company’s Annual Report and Corporate Social Responsibility report. This report provides an in-depth look into Gilead’s commitment to develop and deliver innovative therapies that change lives.

PatientsLikeMe and Shire Pharmaceuticals Collaborate to Study Rare Genetic Diseases

Mon, 04/24/2017 - 12:30

PatientsLikeMe and Shire plc have announced a new collaboration that will support the development of a patient-centered, real world health learning system that expands understanding of patient health and disease.

Aramark Launches Feed Your Potential 365 Campaign to Improve Consumer Health

Wed, 04/12/2017 - 17:00

As part of its five-year commitment with the American Heart Association to improve the health of Americans 20 percent by 2020, Aramark (NYSE: ARMK), a global leader in food, facilities management and uniforms, is launching Feed Your Potential 365, a public health and well-being campaign, to promote healthy lifestyles among all consumers, as well as families in underserved communities and Aramark’s customers, clients and employees.

Cancer in the Community: Understanding and Addressing Cultural Forces

Wed, 04/05/2017 - 12:00

Improving Diagnostic Pathways for Rare Disease Patients

Mon, 04/10/2017 - 12:00

It can take longer to diagnose rare diseases than many common diseases. On average, rare disease diagnosis takes 7.6 years in the U.S. and 5.6 years in the UK. Rare diseases such as the primary immunodeficiency (PI) disorders Gaucher disease, Fabry disease, and Hunter syndrome can be devastating, as they are difficult to detect and equally difficult to treat.